|
Dec 20
|
Anavex (AVXL) Rises as CHMP Deems Blarcamesine Eligible for MAA
|
|
Dec 19
|
Invivyd (IVVD) Surges on Positive Data From COVID-19 Study
|
|
Dec 8
|
With 39% ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) has piqued the interest of institutional investors
|
|
Dec 8
|
Kymera (KYMR) Rises as Dosing Begins in AD Study on KT-474
|
|
Dec 7
|
Syros (SYRS) Rises on Upbeat Initial Study Data on Tamibarotene
|
|
Dec 5
|
Alterity (ATHE) Up on Preclinical Parkinson's Treatment Data
|
|
Dec 1
|
AstraZeneca (AZN) to Discontinue Two Studies on Lokelma
|
|
Nov 30
|
AbbVie (ABBV) Posts Encouraging Data From Lung Cancer Study
|
|
Nov 30
|
Adaptimmune (ADAP) Rises as GSK Transfers T-Cell Therapy IND
|
|
Nov 29
|
Emergent (EBS) Gets $75M BARDA Contract for Anthrax Vaccine
|
|
Nov 29
|
Immunovant (IMVT) Up on Positive Initial IMVT-1402 MAD Study Data
|
|
Nov 29
|
SpringWorks (SWTX) Rises on FDA Nod for Desmoid Tumor Drug
|
|
Nov 28
|
AbbVie (ABBV) Lymphoma Drug Gets FDA Breakthrough Therapy Tag
|
|
Nov 28
|
TC BioPharm (TCBP) Falls Despite FDA Clearing IND for AML Drug
|
|
Jul 20
|
Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2023 Financial Results
|